Skip to main content
FendX Technologies logo

FendX Technologies — Investor Relations & Filings

Ticker · FNDX ISIN · CA3144602057 CSE Manufacturing
Open in API
Filings indexed 174 across all filing types
Latest filing 2025-04-17 Share Issue/Capital Cha…
Country CA Canada
Listing CSE FNDX

About FendX Technologies

https://fendxtech.com/

FendX Technologies develops and commercializes advanced surface protection solutions leveraging proprietary nanotechnology. The company's core focus is creating protective nano-coatings designed to significantly repel and reduce the adherence of bacteria, viruses, blood, and other liquids from surfaces. These advanced coatings are targeted for use on high-touch surfaces and specific medical applications, including Foley catheters, aiming to reduce contamination and the spread of pathogens. FendX is also advancing an AI-powered mobile application for real-time monitoring of surface hygiene and exploring novel disinfectant formulations that balance effective antimicrobial performance with environmental safety.

Recent filings

Filing Released Lang Actions
Material change report - English.pdf
Share Issue/Capital Change Classification · 1% confidence The document is a Canadian NI 51-102F3 “Material Change Report” describing a share-for-debt transaction in which the company issued 400,000 common shares to settle debt. This is an announcement of a new share issuance/capital change. Accordingly, it falls under “Share Issue/Capital Change” (SHA).
2025-04-17 English
News release - English.pdf
Share Issue/Capital Change Classification · 1% confidence The document is a corporate press release announcing the completion of a share-for-debt transaction whereby the company issued common shares to settle debt. This is clearly an announcement of a new share issuance and thus falls under the category for share issue or capital change (SHA).
2025-04-17 English
News release - English.pdf
Regulatory Filings Classification · 1% confidence The document is a corporate press release by FendX Technologies Inc. discussing CDC reports on antimicrobial resistance and highlighting the company’s product development activities and forward-looking statements. It does not present financial results (not an Earnings Release or Annual/Interim Report), nor does it announce dividends, share issues, or governance changes. It is a general news/regulatory announcement with no specific category, so it falls under the fallback “Regulatory Filings” category (RNS).
2025-04-09 English
News release - English.pdf
Capital/Financing Update Classification · 1% confidence The document is a shareholder letter/news release providing a corporate update on business development, nanotechnology progress, intellectual property, and notably detailed capital markets activities: a private placement of $710,005 in March 2025 and the intention to complete a share-for-debt settlement. These elements are classic “Capital/Financing Update” content, covering fundraising and capital structure changes rather than a formal annual or interim report. Therefore, the appropriate classification is CAP.
2025-04-07 English
News release - English.pdf
Share Issue/Capital Change Classification · 1% confidence The document is a press release announcing the grant of stock options and restricted share units to directors, officers, employees and consultants. This constitutes a corporate action altering the company’s capital structure (new equity‐linked awards). It is not a sale or buyback but represents an issuance of share rights, which fits the “Share Issue/Capital Change” category under code SHA.
2025-03-22 English
Report of exempt distribution (45-106F1).pdf
Regulatory Filings Classification · 1% confidence The document is a completed regulatory form titled “Form 45-106F1 Report of Exempt Distribution,” which is a mandatory filing under Canadian securities regulations (NI 45-106) used to report exempt share distributions. It is not an earnings release, proxy, management discussion, annual or interim report, nor a simple notice of dividend or capital change announcement. It is a specialized regulatory disclosure and does not fit more specific categories, making “Regulatory Filings” (RNS) the appropriate classification.
2025-03-21 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.